Non-Hodgkin Lymphoma /Features

Innovative Medicines Initiative approves €40 million HARMONY project for better care of patients with hematologic malignancies

The Innovative Medicines Initiative (IMI) has approved HARMONY, a project that aims to foster better access and care for patients…

Acute Myeloid Leukemia Chronic Lymphocytic Leukemia Multiple Myeloma Myelodysplastic Syndromes Non-Hodgkin Lymphoma
2 years

Solving the CARD11 puzzle and gaining a deeper understanding of oncogenic mutations

CARD11 is a scaffold protein that is critical for antigen receptor signaling. Normally, it is locked in an “off” position…

Non-Hodgkin Lymphoma
3 years
VJHemOnc is intended for Healthcare Professionals only

By choosing to continue, you are confirming that you are a healthcare professional

VJHO needs the contact information you provide to inform you about our latest hemonc news and videos, educational courses and industry supported content (some of which may be promotional in nature). You may unsubscribe from these communications at anytime. For information on how to unsubscribe, as well as our privacy practices and commitment to protecting your privacy, check out our Privacy Policy.

The content of VJHemOnc is intended for healthcare professionals